ArticleCancer chemotherapy and pharmacology2025

Impact of adverse events on survival outcomes in patients treated with CDK4/6 inhibitors for advanced breast cancer.

Martina Catalano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.